Afluria
Product Images NDC 33332-125

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Afluria (NDC 33332-125). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Seqirus Pty Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Principal Display Panel – 5 mL Carton Label (Afl0h 0014 01)

Principal Display Panel – 5 mL Carton Label (Afl0h 0014 01)
Afluria 2024-2025 Formula influenza vaccine multi-dose vial carton, labeled for intramuscular use in persons 6 months and older. The 5 mL vial is prescription only and distributed by Seqirus PTY LTD. The packaging features storage instructions, vaccine composition details, and the Seqirus logo on a pink and blue color scheme.*
FDA Label Image

Principal Display Panel – 5 mL Vial Label (Afl0h 0014 02)

Principal Display Panel – 5 mL Vial Label (Afl0h 0014 02)
Afluria 2024-2025 Formula Influenza Vaccine multi-dose vial label by Seqirus Pty Ltd. The label shows a 5 mL multi-dose vial, with dosage instructions for intramuscular use: 0.25 mL for ages 6-35 months and 0.5 mL for ages 3 years and older. Storage instructions specify 2-8°C with a warning to not freeze and to shake well. It includes the NDC 33332-124-11 and manufacturing information for Seqirus Pty Ltd in Australia and distribution by Seqirus USA Inc.*
FDA Label Image

Principal Display Panel – 0.5 mL Carton Label (Afl0h 0014 03)

Principal Display Panel – 0.5 mL Carton Label (Afl0h 0014 03)
Box label for Afluria Influenza Vaccine 2024-2025 Formula by Seqirus Pty Ltd. The packaging indicates it is for intramuscular use in persons 3 years and older. Contains 10 pre-filled syringes, each with a 0.5 mL dose. The label includes storage instructions and mentions it is free from preservatives and natural rubber latex.*
FDA Label Image

Principal Display Panel – 0.5 mL Vial Label (Afl0h 0014 04)

Principal Display Panel – 0.5 mL Vial Label (Afl0h 0014 04)
Label for Afluria influenza vaccine, 0.5 mL dosage form, for intramuscular use in individuals 3 years and older. The label includes NDC 33332-024-04 and indicates manufacturing by Seqirus Pty Ltd, Parkville, Australia. The 2024-2025 formula is specified along with US license number 2044 and usage restrictions (Rx only).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.